Showing results (71-80 of 384) with videos related to

Sort By:
Pageof 39
Urology|February 25, 2017
Patterns of Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy for Low-risk MenHeather J Chalfin, Zhaoyong Feng, Bruce J Trock, et al.
The Journal of Urology|June 4, 2013
Adenocarcinoma of the prostate with Gleason score 9-10 on core biopsy: correlation with findings at radical prostatectomy and prognosisCarla L Ellis, Alan W Partin, Misop Han, et al.
The Prostate|December 29, 2006
Antibody array profiling reveals serum TSP-1 as a marker to distinguish benign from malignant prostatic diseaseMichael W Shafer, Leslie Mangold, Alan W Partin, et al.
BJU International|July 9, 2011
Effect of intra-observer variation in prostate volume measurement on prostate-specific antigen density calculations among prostate cancer active surveillance participantsJoan S Ko, Patricia Landis, H Ballentine Carter, et al.
The Journal of Urology|December 11, 2003
An evaluation of the decreasing incidence of positive surgical margins in a large retropubic prostatectomy seriesMisop Han, Alan W Partin, David Y Chan, et al.
The Journal of Urology|February 2, 2021
Tobacco Screening and Treatment during Outpatient Urology Office Visits in the United StatesAri P Bernstein, Marc A Bjurlin, Scott E Sherman, et al.
Cancer Treatment and Research Communications|October 22, 2020
Knowledge and practice regarding prostate cancer germline testing among urologists: Gaps to address for optimal implementation<sup>✰,✰✰</sup>Stacy Loeb, Nataliya Byrne, Dawn Walter, et al.
Urologic Oncology|January 22, 2019
Disparities in the diagnostic evaluation of microhematuriaand implications for the detection of urologic malignancyRichard S Matulewicz, Alysen L Demzik, John Oliver DeLancey, et al.
Urology|January 30, 2004
Prostate-specific antigen doubling time in the identification of patients at risk for progression after treatment and biochemical recurrence for prostate cancerGlenn M Cannon, Patrick C Walsh, Alan W Partin, et al.
Urology|October 18, 2002
Impact of age on total and complexed prostate-specific antigen cutoffs in a contemporary referral series of men with prostate cancerRobert W Veltri, M Craig Miller, Gerard J O'dowd, et al.
Pageof 39